Insights from 2023 SABCS


 

SABCS 2023 Insights: "OPERA-01 Study of Palazestrant vs. Standard-of-Care Treatment for ER+, HER2- Advanced or mBC After ET & CDK4/6i"

94 views
January 3, 2024
Comments 0
Login to view comments. Click here to Login